Sun Pharmaceutical Industries Share Price Today - Live Blog for December 11, 2025

Sun Pharmaceutical Industries Ltd experienced a substantial 0.09% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,808.00, making it an appealing option for investors.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.04% slump and is currently trading at ₹1,807.50. While the stock maintains a PE ratio of 41.3000, the industry PE is 33.3992, raising questions about valuation.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.13% recently. As of now, this stock is actively trading at a current market price of ₹1,808.25 per share, attracting attention from investors.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.13% increase and currently trading at ₹1,808.25 per share. Investors are taking notice of this upward momentum.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.13% increase and currently trading at ₹1,808.25 per share. Investors are taking notice of this upward momentum.

Following a noteworthy 0.13% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,808.25. When it comes to valuation, this stock has a PE ratio of 41.3000, with the industry PE ratio at 33.3992.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.22% increase in its share price and is currently trading at ₹1,806.00. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,801.55. With the stock's PE at 41.3000 and the industry PE at 33.3992, investors are weighing their options.

Sun Pharmaceutical Industries Ltd stock remained unchanged, maintaining its position at ₹1,800.80. During this period of price stability, investors can assess the stock's competitive advantages and market positioning.

After a -0.02% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,800.50. The stock has a PE ratio of 41.3000, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Demonstrating a commendable 0.07% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,801.10. In terms of valuation, the stock maintains a PE ratio of 41.3000, while the industry PE ratio stands at 33.3992.

Following a noteworthy 0.11% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,799.05. When it comes to valuation, this stock has a PE ratio of 41.3000, with the industry PE ratio at 33.3992.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.13%, with the current market value at ₹1,796.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a remarkable 0.03% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,798.50. Notably, this stock has a Price-to-Earnings (PE) ratio of 41.3000, while the industry's PE ratio is 33.3992.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.06%, with its current market value per share resting at ₹1,798.50. This development highlights the stock's appeal to investors.

Demonstrating a commendable 0.03% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,797.40. In terms of valuation, the stock maintains a PE ratio of 41.3000, while the industry PE ratio stands at 33.3992.

Demonstrating a commendable 0.21% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,798.75. In terms of valuation, the stock maintains a PE ratio of 41.3000, while the industry PE ratio stands at 33.3992.

Sun Pharmaceutical Industries Ltd shares saw a -0.05% decrease, reaching a current market price of ₹1,795.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 41.3000, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.03% drop, and it's now trading at ₹1,795.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.24% surge in its share price and is presently trading at ₹1,795.90, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.24%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,788.60, and market participants are assessing the implications. The stock has a PE ratio of 41.3000, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,792.85. Additionally, the stock maintains a PE ratio of 41.3000, while the industry PE is 33.3992.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.12%, and as of now, it's trading at ₹1,792.85 per share. This upward trajectory is attracting keen interest from investors.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.43% increase and currently trading at ₹1,789.75 per share. Investors are taking notice of this upward momentum.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.02% increase and currently trading at ₹1,781.20 per share. This upward trajectory is turning heads in the market.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.08% decline, and it currently trades at ₹1,781.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a remarkable 0.07% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,785.15. Notably, this stock has a Price-to-Earnings (PE) ratio of 41.3000, while the industry's PE ratio is 33.3992.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.20% increase and currently trading at ₹1,786.40 per share. This upward trajectory is turning heads in the market.

After a notable 0.44% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,782.75. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.